Skip to main content
DARE logo

Daré Bioscience, Inc. (DARE)

DARENASDAQHealthcareBiotechnology

$0.41Today:+$0.00 (+0.44%)1Y −73.10%

As of Nov 20, 2026 close

Market cap
$6.73M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.41$3.78
Volume (live)
-
Avg. volume (3M)
172.89K

Daré Bioscience (DARE) Income Statement

Daré Bioscience reported revenue of $1.03M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 10429.4% from $9.78K a year earlier. Daré Bioscience posted a net loss of $13.40M, compared with a net loss of $4.05M a year earlier. Gross margin was 71.3% and operating margin −1315.5%. In the most recent quarter, Q3 fiscal 2026 (ended Sep 30, 2026), revenue was $47.63K, up 2005.6% from the same quarter a year earlier.

Daré Bioscience Income Statement Analysis

Values in millions USD

Scroll to see more
Daré Bioscience, Inc. income statement - Annual data in millions USD
BreakdownTTMFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingSep 2026Dec 2025Mar 2025Dec 2024Dec 2023Dec 2022Mar 2022Dec 2021Dec 2020Dec 2019Mar 2019Dec 2017
Revenue & Gross Profit
Revenue1.411.030.010.012.8110.000.00-0.000.000.000.00
Cost of Revenue1.840.3014.3114.3121.6430.140.100.100.080.010.630.00
Gross Profit-0.420.73-14.300.01-18.83-20.14-0.10-0.10-0.08-0.010.000.00
Operating Expenses
Research & Development1.345.5214.2114.3121.5430.0430.6230.6220.778.556.410.98
Selling, General & Administrative9.068.769.169.1611.9111.248.358.356.555.795.282.71
Operating Expenses10.1114.299.1623.4611.9141.3938.9738.9727.3214.3311.703.69
Operating Income-10.53-13.55-23.45-23.45-30.74-31.39-39.07-39.07-27.40-14.34-16.88-11.18
Other Income/Expense
Interest Income-0.680.00-0.000.000.00-0.000.000.000.00
Interest Expense-0.820.00-0.000.000.00-0.000.000.000.32
Other Income/Expense-0.050.1519.4019.400.780.440.370.370.000.08143.50-0.32
Income
Income Before Tax-10.58-13.40-4.05-4.05-30.16-30.95-38.70-38.70-27.40-14.26-16.74-11.50
Income Tax Expense-0.000.00-0.000.000.00-0.000.0010.230.00
Net Income-10.58-13.40-4.05-4.05-30.16-30.95-38.70-38.70-27.40-14.26-16.74-11.50
Net Income - Continuous Operations-10.58-13.40-4.05-4.05-30.16-30.95-38.70-38.70-27.40-14.26-16.74-11.50
Net Income - Discontinued Operations------------
EBITDA-8.16-11.92-4.01-23.41-30.70-31.36-38.67-39.04-27.36-14.25-11.69-11.18
EBIT-10.53-13.55--23.45-30.74-31.39--39.07-27.40---
Depreciation & Amortization2.171.630.040.040.040.020.030.030.040.010.002.73
Earnings Per Share
Basic EPS-0.38-1.20--0.48-4.15-4.44-8.00-7.59-11.00-11.00-30.00-4.00
Diluted EPS-0.38-1.20--0.48-4.15-4.44-8.00-7.59-11.00-11.00-30.00-4.00
Basic Shares Outstanding15.3311.188.508.507.287.055.105.102.511.300.890.27
Diluted Shares Outstanding15.3311.188.508.507.287.055.105.102.511.300.890.27

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Daré Bioscience Financial Statements

What was Daré Bioscience's revenue in fiscal 2025?

Daré Bioscience reported revenue of $1.03M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 10429.4% from $9.78K a year earlier.

Is Daré Bioscience profitable?

No. Daré Bioscience reported a net loss of $13.40M in fiscal 2025. In fiscal 2024 it lost $4.05M.

What is Daré Bioscience's operating margin?

Daré Bioscience's operating income was −$13.55M on revenue of $1.03M in fiscal 2025, an operating margin of −1315.5%, compared with −239692.2% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition